BioGrad has opened Europe’s first private women’s health research tissue bank as part of a £25 ($30.7) million investment. 

Focused on the collection and storage of menstrual blood, peripheral blood, umbilical cord tissue, and umbilical cord blood, BioGrad is calling on females of all backgrounds aged 13 and above to donate.  

The aim is to uncover potential cures or treatments for conditions such as polycystic ovarian syndrome (PCOS), endometriosis, menopause, and certain cancers.  

The company’s goals are to drive stem cell and immunotherapy research, investigate the ‘why and how’ behind these conditions and pave the way for breakthrough treatments and potential cures aiming to improve quality of life. 

BioGrad has established strong relationships with hospitals including Liverpool Women’s Hospital, and other leading hospitals in the Liverpool City Region.  

The company says this new opening signals a major step forward in addressing inequalities in healthcare and unlocking the potential for groundbreaking medical discoveries. 

Dr Natalie Kenny, CEO, BioGrad, said: “For far too long women’s health has been an afterthought in scientific research. At BioGrad, we are proud to be leading the charge in changing this narrative. By opening Europe’s first dedicated private women’s health research tissue bank, we are not only addressing a critical gap in medical research but also empowering women to play a direct role in advancing healthcare and patient outcomes.” 

Lynn Greenhalgh, Medical Director, Liverpool’s Women’s Hospital, added: “The tissue bank will create a resource for the North of England for researchers in women’s health which will allow quicker access to samples for research. This will enable more women to benefit from a greater understanding and potentially new treatments for women’s health problems that affect such a large part of the population.”

Diana Spencer, Senior Digital Content Editor, DDW